Retroviridae

Retroviridae
Translated by Raul654 · CC BY-SA 3.0 · source
Name	Retroviridae
Virus group	Group VI (Baltimore classification)
Realm	Riboviria
Realm rank	Realm
Family	Retroviridae
Order	Ortervirales
Subdivisions	Alpharetrovirus; Betaretrovirus; Gammaretrovirus; Deltaretrovirus; Epsilonretrovirus; Lentivirus; Spumaretrovirus

Retroviridae Retroviridae is a diverse family of enveloped RNA viruses characterized by reverse transcription of their RNA genome into DNA within infected cells, a process studied in contexts such as Nobel Prize-winning work by Howard Temin and David Baltimore. Members of the family include clinically important pathogens like those investigated by researchers at institutions such as Centers for Disease Control and Prevention and World Health Organization, and have been central to studies at universities including Harvard University, University of Cambridge, and Massachusetts Institute of Technology. Retroviridae viruses have influenced disciplines spanning virology research at Cold Spring Harbor Laboratory and evolutionary biology discussed at conferences like the Society for Molecular Biology and Evolution annual meeting.

Taxonomy and Classification

The family is placed in the order Ortervirales and the realm Riboviria, with taxa defined by criteria used by the International Committee on Taxonomy of Viruses; historical classification was influenced by early work at Rockefeller University and taxonomic revisions similar to those debated at the International Union of Microbiological Societies. Major genera include Alpharetrovirus, Betaretrovirus, Gammaretrovirus, Deltaretrovirus, Epsilonretrovirus, Lentivirus, and Spumaretrovirus, with type species designated following proposals presented at meetings held by the International Congress of Virology. Host range decisions and species demarcation reflect studies from field sites like Centers for Disease Control and Prevention surveillance programs and longitudinal cohorts run by National Institutes of Health-funded networks.

Virology and Structure

Retroviridae virions are enveloped, roughly spherical particles with surface glycoproteins and an internal capsid enclosing two copies of positive-sense single-stranded RNA; structural elucidation has been advanced by laboratories at Max Planck Society and cryo-EM facilities at European Molecular Biology Laboratory. The envelope bears viral Env glycoproteins that mediate receptor binding to host proteins first identified in cell-surface studies at Salk Institute and binding assays used by groups at Johns Hopkins University Hospital. The Gag polyprotein directs capsid assembly as analyzed in structural studies at Wadsworth Center and protein processing by the viral protease, work central to antiviral drug development in collaborations between GlaxoSmithKline and academic labs at University of Oxford.

Genome and Replication Cycle

Retroviridae genomes are typically 7–12 kilobases in length and encode canonical genes gag, pol, and env, with accessory genes characterized in pathogenic species by teams at Institut Pasteur and geneticists at University of California, San Francisco. Entry begins with receptor engagement and fusion studied in virology groups at Yale University School of Medicine; reverse transcription, a hallmark mechanism demonstrated by Howard Temin and David Baltimore, generates double-stranded proviral DNA. Integration of proviral DNA into host chromosomes is catalyzed by integrase proteins whose inhibitors were developed through collaborations including Merck & Co. and clinical trials overseen by regulatory agencies like Food and Drug Administration (United States). Transcription from integrated provirus is regulated by viral promoters and host transcription factors identified in research at Stanford University and epigenetic studies from European Research Council-funded consortia.

Pathogenesis and Diseases

Members of Retroviridae cause diseases in a range of hosts: Lentiviruses include human pathogens studied at UNAIDS and clinical centers such as Massachusetts General Hospital; Gammaretroviruses and Deltaretroviruses are linked to oncogenesis and leukemias explored in oncology units at Memorial Sloan Kettering Cancer Center and cancer research presented at the American Association for Cancer Research meetings. Retroviral pathogenesis involves immune evasion processes characterized by immunology groups at The Scripps Research Institute and chronic infection cohorts supported by Wellcome Trust. Zoonotic spillover events, host-range shifts, and viral transmission dynamics have been topics at the World Health Assembly and field studies coordinated with agencies like United States Agency for International Development.

Diagnosis and Treatment

Diagnostic approaches include nucleic acid amplification tests and serology developed by commercial laboratories such as Abbott Laboratories and used in public health programs by Public Health England; viral load monitoring and CD4 counts for lentiviral infections are standard of care in clinics affiliated with Johns Hopkins Hospital. Antiretroviral therapy regimens, including reverse transcriptase inhibitors and protease inhibitors, were developed through research collaborations involving Gilead Sciences and Bristol-Myers Squibb and tested in multicenter trials coordinated by networks like INSIGHT and ACTG. Preventive measures, including pre-exposure prophylaxis evaluated in studies sponsored by Bill & Melinda Gates Foundation and vaccine research conducted at National Institutes of Health vaccine centers, remain active areas of clinical research.

Evolution and Endogenous Retroviruses

Retroviridae evolution is traced through comparative genomics projects led by institutions such as Broad Institute and paleovirology studies from researchers at University of Oxford; endogenous retroviruses (ERVs) result from ancient germline integrations and are abundant in vertebrate genomes cataloged by consortia including the Genome Reference Consortium. ERVs have been implicated in gene regulation and placental biology, with seminal contributions from investigators at Max Planck Institute for Evolutionary Anthropology and developmental studies presented at the European Society of Human Genetics conferences. Phylogenetic frameworks for Retroviridae diversification have been refined using datasets from the 1000 Genomes Project and comparative analyses published in journals affiliated with Nature Publishing Group and American Association for the Advancement of Science.

Category:Viruses